Clinical Trial Update: Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update assessing safety, tolerability, and preliminary efficacy of ALS-357 in patients with cutaneous metastatic melanoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• ALS-357

Snippet

Sponsor: Advanced Life Sciences, Inc. | Conditions: Melanoma | Phase 1 | Status: UNKNOWN